ENGOT-EN11/GOG-3053/KEYNOTE-B21

Trial Description: 
A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus placebo in combination with adjuvant chemotherapy with or without radiotherapy for the treatment of newly diagnosed High-Risk Endometrial Cancer after surgery with curative Intent
Lead Cooperative Group: 
Trial Number: 

EudraCT: 2020-003424-17

Disease Site: 
Endometrial
Trial Status: 
Closed to Recruitment
Contact person: 
tvgorp